Literature DB >> 1704037

Functional comparison of the upstream regulatory DNA sequences of four human epidermal keratin genes.

C K Jiang1, H S Epstein, M Tomic, I M Freedberg, M Blumenberg.   

Abstract

The promoters of epidermal keratin genes, K5, K6, and K10 were cloned and their functions compared with that of the previously described promoter of the K14 keratin gene in non-epithelial and transformed epithelial cell lines, as well as in primary cultures of cells derived from simple and stratified epithelia. The four promoters were functional only in epithelial cells. Although the promoter for the basal cell-specific, acidic-type K14 gene was active in all epithelial cells tested, its basic-type partner, K5, and the promoter for the hyper-proliferation-associated K6 were active only in primary cultures of stratified epithelia. The promoter for the epidermal differentiation-specific K10 keratin gene was active at a low level in primary cultures of stratified epithelial cells on non-epidermal origin. Thus, the K14 gene promoter is functional in all epithelial cells, but the upstream regions of the K5 and K6 keratin genes restrict their expression to stratified epithelia, whereas the epidermal determinants of the K10 gene are not in the proximal upstream sequences.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1704037     DOI: 10.1111/1523-1747.ep12460939

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  10 in total

1.  Clues to epidermal cancer proneness revealed by reconstruction of DNA repair-deficient xeroderma pigmentosum skin in vitro.

Authors:  F Bernerd; D Asselineau; C Vioux; O Chevallier-Lagente; B Bouadjar; A Sarasin; T Magnaldo
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-03       Impact factor: 11.205

2.  Uptake and presentation of exogenous antigen and presentation of endogenously produced antigen by skin dendritic cells represent equivalent pathways for the priming of cellular immune responses following biolistic DNA immunization.

Authors:  Stephan Sudowe; Sabine Dominitzki; Evelyn Montermann; Matthias Bros; Stephan Grabbe; Angelika B Reske-Kunz
Journal:  Immunology       Date:  2008-09-17       Impact factor: 7.397

3.  Probing keratinocyte and differentiation specificity of the human K5 promoter in vitro and in transgenic mice.

Authors:  C Byrne; E Fuchs
Journal:  Mol Cell Biol       Date:  1993-06       Impact factor: 4.272

4.  On the role of AP2 in epithelial-specific gene expression.

Authors:  T Magnaldo; R G Vidal; M Ohtsuki; I M Freedberg; M Blumenberg
Journal:  Gene Expr       Date:  1993

5.  A cluster of five nuclear proteins regulates keratin gene transcription.

Authors:  M Ohtsuki; S Flanagan; I M Freedberg; M Blumenberg
Journal:  Gene Expr       Date:  1993

6.  Transcriptional control in keratinocytes and fibroblasts using synthetic ligands.

Authors:  R A Freiberg; S N Ho; P A Khavari
Journal:  J Clin Invest       Date:  1997-06-01       Impact factor: 14.808

7.  Epidermal growth factor and transforming growth factor alpha specifically induce the activation- and hyperproliferation-associated keratins 6 and 16.

Authors:  C K Jiang; T Magnaldo; M Ohtsuki; I M Freedberg; F Bernerd; M Blumenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1993-07-15       Impact factor: 11.205

8.  Expression of the carcinoma-associated keratin K6 and the role of AP-1 proto-oncoproteins.

Authors:  F Bernerd; T Magnaldo; I M Freedberg; M Blumenberg
Journal:  Gene Expr       Date:  1993

9.  Disease-activated transcription factor: allergic reactions in human skin cause nuclear translocation of STAT-91 and induce synthesis of keratin K17.

Authors:  C K Jiang; S Flanagan; M Ohtsuki; K Shuai; I M Freedberg; M Blumenberg
Journal:  Mol Cell Biol       Date:  1994-07       Impact factor: 4.272

10.  Induction of oxidative stress responses by dioxin and other ligands of the aryl hydrocarbon receptor.

Authors:  John F Reichard; Timothy P Dalton; Howard G Shertzer; Alvaro Puga
Journal:  Dose Response       Date:  2006-05-01       Impact factor: 2.658

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.